MetaCap

Tempest Therapeutics Statistics

NASDAQ: TPSTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.287-0.0189 (-6.18%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Tempest Therapeutics by the numbers

Tempest Therapeutics has a market capitalization of $5.7 million based on 20.00M shares outstanding. With trailing EPS of $-3.16, Tempest Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 54.1% below its 50-day average and 78.4% below its 200-day average.

Average daily trading volume is 2.56M shares, or about $734,945 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TPST valuation vs. peer median

TPST compared with the median of 8 peer companies
MetricTPSTPeer medianDifference
Market cap$5.74M$5.75M-0%
Avg. volume2.56M106.32K+2308%

Peer median across 8 companies: LGVN, XCUR, TOVX, ENVB, UPC, ADXN, CNSP, ACXP.

Valuation

Price and trading

Previous close
0.3059
Open
0.2967
Day range
0.2803 – 0.2968
52-week range
0.28 – 4.22
52-week change
-91.80%
Beta
—
Volume
145.31K

Dividends and events

Annual dividend
None
Next earnings date
Nov 13, 2026

Additional statistics

Market Cap
5.74M
Forward Pe
-0.59
Eps
-3.16
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
4.22
Week52 Low
0.28
Avg Volume
2.56M
Shares Outstanding
20.00M
Ma50
0.63
Ma200
1.33
Earnings Date
Nov 13, 2026
Pct From52w High
-93.20%
Pct From52w Low
2.50%

Related